SVA
SVA clinical trials: SINOVAC BIOTECH LTD
Every trial on ClinicalTrials.gov where SINOVAC BIOTECH LTD is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 119
- Trials linked
- 115
- As lead sponsor
- 4
- As collaborator
- 6
- Primary completions as lead sponsor, next 90 days
SVA on the catalyst calendar · SVA registry changes
- Primary completion Feb 2027Sponsor estimatePhase 4NCT07832201A Phase IV Clinical Trial of Influenza Vaccine (Split Virion), Inactivatedin (Anflu®) Pregnant Women (AnFLU-PREG)Sinovac Biotech Co., Ltd · InfluenzaRecruitingSVALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 15, 2026ActualPhase 3NCT07416110Phase IIIb Clinical Trial to Evaluate Lot-to-lot Consistency of Sinovac Rabies VaccineSinovac Biotech Co., Ltd · Rabies (Healthy Volunteers)Active, not recruitingSVALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 26, 2026ActualPhase 3NCT07211152Influenza Vaccine (Split Virion), Inactivated, Quadrivalent in Pregnant WomenSinovac Biotech Co., Ltd · InfluenzaCompletedSVALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Nov 30, 2026Sponsor estimateNo phase registeredNCT07889219Study on the Long-Term Persistence of Immunity Induced by Inactivated Hepatitis A VaccineSinovac Biotech Co., Ltd · Hepatitis ARecruitingSVALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 2026Sponsor estimatePhase 1NCT07889193Phase I Clinical Trial of Trivalent Inactivated Split Influenza Virus Vaccine (MDCK Cell)Sinovac Biotech Co., Ltd · Seasonal InfluenzaNot yet recruitingSVALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 9, 2026ActualNo phase registeredNCT07855705A Study to Evaluate the 17-Year Immune Persistence of a Single Dose of Inactivated Hepatitis A VaccineSinovac Biotech Co., Ltd · Hepatitis ACompletedSVALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 18, 2025ActualPhase 1NCT07737106Phase I Clinical Trial of Influenza Vaccine (Split Virion), Inactivated (High Dose)Sinovac Biotech Co., Ltd · InfluenzaCompletedSVALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 9, 2027Sponsor estimateNo phase registeredNCT07793175Bridging Clinical Trial of EV71 Vaccine in Vietnamese ChildrenSinovac Biotech Co., Ltd · Hand, Foot, and Mouth Disease (HFMD)Not yet recruitingSVALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 15, 2027Sponsor estimatePhase 3NCT07793227Phase Ⅲ Clinical Trial of an Inactivated Hepatitis A VaccineSinovac Biotech Co., Ltd · Hepatitis A VaccineRecruitingSVALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Nov 2026Sponsor estimatePhase 3NCT07505888Phase Ⅲ Trial of Group ACYW135 Meningococcal Conjugate Vaccine in Children Aged 2-6 YearsSinovac Biotech Co., Ltd · Epidemic MeningitisActive, not recruitingSVALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 2027Sponsor estimatePhase 3NCT07505836Phase Ⅲ Trial of Group ACYW135 Meningococcal Conjugate Vaccine in Children Aged 12-23 MonthsSinovac Biotech Co., Ltd · Epidemic MeningitisRecruitingSVALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 2027Sponsor estimatePhase 3NCT07505823Phase Ⅲ Trial of Group ACYW135 Meningococcal Conjugate Vaccine in Children Aged 6-11 MonthsSinovac Biotech Co., Ltd · Epidemic MeningitisRecruitingSVALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 2027Sponsor estimatePhase 3NCT07505810Phase Ⅲ Trial of Group ACYW135 Meningococcal Conjugate Vaccine in Children Aged 3-5 MonthsSinovac Biotech Co., Ltd · Epidemic MeningitisRecruitingSVALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 19, 2025ActualPhase 1/Phase 2NCT06063057Inactivated Bivalent Enterovirus Vaccine (Vero Cell) Phase I/II Clinical TrialSinovac Biotech Co., Ltd · Hand, Foot and Mouth DiseaseCompletedSVALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 2027Sponsor estimatePhase 3NCT07611513Protective Efficacy , Immunogenicity and Safety of the Tetravalent Inactivated Enterovirus Vaccine (Vero Cell).Sinovac Biotech Co., Ltd · Hand, Foot, and Mouth Disease(HFMD)Not yet recruitingSVALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 8, 2026Sponsor estimatePhase 4NCT07457060Phase IV Clinical Study of Sequential Vaccination of Sabin Strain and Wild Strain Inactivated Poliovirus VaccineSinovac Biotech Co., Ltd · PoliomyelitisRecruitingSVALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 30, 2025ActualPhase 1/Phase 2NCT06754384Tolerability, Safety, and Immunogenicity of Tetravalent Inactivated Enterovirus Vaccine (Vero Cell).Sinovac Biotech Co., Ltd · Hand, Foot, and Mouth Disease (HFMD)CompletedSVALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 30, 2026Sponsor estimatePhase 1NCT07418229Study to Evaluate the Safety of a Lyophilized RSV mRNA VaccineSinovac Biotech Co., Ltd · RSVNot yet recruitingSVALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 31, 2026Sponsor estimatePhase 1/Phase 2NCT07400003Study to Evaluate the Safety and Immunogenicity of a Lyophilized Herpes Zoster Virus mRNA VaccineSinovac Biotech Co., Ltd · Herpes ZosterRecruitingSVALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 26, 2025ActualPhase 1NCT06183216A Phase 1b Clinical Trial of 13-valent Pneumococcal Polysaccharide Conjugate VaccineSinovac Research and Development Co., Ltd. · Pneumococcal Infectious DiseaseCompletedSVALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 21, 2022ActualPhase 3NCT07357545Immunogenicity and Safety Assessment of Rabies Vaccine (Vero Cell) for Human Use, Freeze-driedSinovac Biotech Co., Ltd · Rabies (Healthy Volunteers)CompletedSVALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 11, 2026Sponsor estimatePhase 4NCT07354269Phase IV Clinical Study of sIPV Administration in Adolescent and Adult PopulationsSinovac Biotech Co., Ltd · PoliomyelitisRecruitingSVALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 10, 2025ActualPhase 4NCT06442449Booster Dose of sIPV Co-administered With MMR and HepA-I.Sinovac Biotech Co., Ltd · PoliomyelitisCompletedSVALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Feb 13, 2025ActualPhase 3NCT05850364A Multi-center, Open-labelled, Randomized, Controlled, Extended Phase Ⅲ Clinical Trial of sIPV VaccineSinovac Biotech Co., Ltd · PoliomyelitisCompletedSVALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 23, 2024ActualPhase 3NCT06049927A Phase III Clinical Trial of Quadrivalent Influenza Vaccine in Healthy Subjects Aged 6 to 35 MonthsSinovac Biotech Co., Ltd · Seasonal InfluenzaCompletedSVALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 25 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScannerShowing the first 25 trials. There are 94 more in this window; the full list is part of TrialScanner.
Unlock with TrialScanner